Allergy/Asthma News

Children who were exposed to opioids prenatally faced greater risks for infection, eczema and dermatitis, and asthma, but not for allergies, anaphylaxis or autoimmune diseases, according to a study published in JAMA Network Open.

A community outreach program decreased health care resource use among children with high-risk asthma in Tennessee by targeting specific barriers to care, according to a report published in Annals of Allergy, Asthma & Immunology.

A phase 3 study subgroup analysis showed that patients with seborrheic dermatitis who cannot use topical steroids were more likely to achieve disease clearance with Zoryve topical foam vs. vehicle, Arcutis announced in a press release.

The prevalence of asthma among Asian American children appeared similar to that of non-Hispanic white children, but asthma risks varied widely within Asian ethnic groups, according to a study in Annals of Allergy, Asthma and Immunology.

Children who begin sublingual immunotherapy for allergic rhinitis at age 5 years have less risk for developing allergic asthma than children who begin this treatment later, according to a study published in Allergy.

Young females using e-cigarettes had greater odds for an asthma attack than young males not using e-cigarettes, according to results published in Annals of the American Thoracic Society.

Insect venom was the cause of most cases of occupational anaphylaxis, followed by food, drugs and latex, according to a study published in Allergy.

CMS has finalized a new final rule that aims to shorten prior authorization timelines and streamline processes to remove barriers to patient care, according to a press release.

Oncologists were satisfied with an electronic system for consulting with allergists about hypersensitivity reactions during chemotherapy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Dupixent for atopic dermatitis has received a label update from the FDA adding phase 3 efficacy and safety data, Regeneron and Sanofi announced in a press release.